These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25501380)
1. Healing refractory venous ulcers: new treatments offer hope. Kirsner RS; Baquerizo Nole KL; Fox JD; Liu SN J Invest Dermatol; 2015 Jan; 135(1):19-23. PubMed ID: 25501380 [TBL] [Abstract][Full Text] [Related]
2. The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial. Ghatnekar GS; Grek CL; Armstrong DG; Desai SC; Gourdie RG J Invest Dermatol; 2015 Jan; 135(1):289-298. PubMed ID: 25072595 [TBL] [Abstract][Full Text] [Related]
3. Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial. Grek CL; Prasad GM; Viswanathan V; Armstrong DG; Gourdie RG; Ghatnekar GS Wound Repair Regen; 2015; 23(2):203-12. PubMed ID: 25703647 [TBL] [Abstract][Full Text] [Related]
4. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. Curran MP; Plosker GL BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767 [TBL] [Abstract][Full Text] [Related]
5. Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. Brandner JM; Houdek P; Hüsing B; Kaiser C; Moll I J Invest Dermatol; 2004 May; 122(5):1310-20. PubMed ID: 15140236 [TBL] [Abstract][Full Text] [Related]
6. Estimating the Clinical Outcomes and Cost Differences Between Standard Care With and Without Cadexomer Iodine in the Management of Chronic Venous Leg Ulcers Using a Markov Model. Nherera LM; Woodmansey E; Trueman P; Gibbons GW Ostomy Wound Manage; 2016 Jun; 62(6):26-40. PubMed ID: 27356144 [TBL] [Abstract][Full Text] [Related]
7. Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study. Pinto NR; Ubilla M; Zamora Y; Del Rio V; Dohan Ehrenfest DM; Quirynen M Platelets; 2018 Jul; 29(5):468-475. PubMed ID: 28727481 [TBL] [Abstract][Full Text] [Related]
8. Chronic venous leg ulcers: is topical zinc the answer? A review of the literature. O'Connor S; Murphy S Adv Skin Wound Care; 2014 Jan; 27(1):35-44; quiz 45-6. PubMed ID: 24343392 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effectiveness of a Calendula officinalis extract in venous leg ulcer healing. Buzzi M; de Freitas F; de Barros Winter M J Wound Care; 2016 Dec; 25(12):732-739. PubMed ID: 27974009 [TBL] [Abstract][Full Text] [Related]
10. Clinical and cost efficacy of advanced wound care matrices for venous ulcers. Hankin CS; Knispel J; Lopes M; Bronstone A; Maus E J Manag Care Pharm; 2012 Jun; 18(5):375-84. PubMed ID: 22663170 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of connexin 43 in human gingival wound healing and fibroblasts. Tarzemany R; Jiang G; Larjava H; Häkkinen L PLoS One; 2015; 10(1):e0115524. PubMed ID: 25584940 [TBL] [Abstract][Full Text] [Related]
12. Ulcer area reduction at 2 weeks predicts failure to heal by 24 weeks in the venous leg ulcers of patients living alone. Parker CN; Finlayson KJ; Edwards HE J Wound Care; 2016 Nov; 25(11):626-634. PubMed ID: 27827277 [TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, controlled trial comparing the effects of noncontact, low-frequency ultrasound to standard care in healing venous leg ulcers. Gibbons GW; Orgill DP; Serena TE; Novoung A; O'Connell JB; Li WW; Driver VR Ostomy Wound Manage; 2015 Jan; 61(1):16-29. PubMed ID: 25581604 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effectiveness and cost of treatment with humid environment as compared to traditional cure. Clinical trial on primary care patients with venous leg ulcers and pressure ulcers]. Capillas Pérez R; Cabré Aguilar V; Gil Colomé AM; Gaitano García A; Torra i Bou JE Rev Enferm; 2000 Jan; 23(1):17-24. PubMed ID: 10788945 [TBL] [Abstract][Full Text] [Related]
15. Aspirin in venous leg ulcer study (ASPiVLU): study protocol for a randomised controlled trial. Weller CD; Barker A; Darby I; Haines T; Underwood M; Ward S; Aldons P; Dapiran E; Madan JJ; Loveland P; Sinha S; Vicaretti M; Wolfe R; Woodward M; McNeil J Trials; 2016 Apr; 17():192. PubMed ID: 27068695 [TBL] [Abstract][Full Text] [Related]
16. Bioglass promotes wound healing by affecting gap junction connexin 43 mediated endothelial cell behavior. Li H; He J; Yu H; Green CR; Chang J Biomaterials; 2016 Apr; 84():64-75. PubMed ID: 26821121 [TBL] [Abstract][Full Text] [Related]
17. Intermittent pneumatic compression: physiologic and clinical basis to improve management of venous leg ulcers. Comerota AJ J Vasc Surg; 2011 Apr; 53(4):1121-9. PubMed ID: 21050701 [TBL] [Abstract][Full Text] [Related]